Combining all-trans retinoid acid treatment targeting myeloid-derived suppressive cells with cryo-thermal therapy enhances antitumor immunity in breast cancer
Targeting myeloid-derived suppressive cells (MDSCs) has been considered a potential strategy in tumor therapy. However, a single drug targeting MDSCs remains a challenge in the clinic. An increasing number of studies have shown that combination agents targeting MDSCs and immunotherapy may provide ex...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1016776/full |
| _version_ | 1828305863063896064 |
|---|---|
| author | Yue Lou Peng Peng Shicheng Wang Junjun Wang Peishan Du Zelu Zhang Jiamin Zheng Ping Liu Lisa X. Xu |
| author_facet | Yue Lou Peng Peng Shicheng Wang Junjun Wang Peishan Du Zelu Zhang Jiamin Zheng Ping Liu Lisa X. Xu |
| author_sort | Yue Lou |
| collection | DOAJ |
| description | Targeting myeloid-derived suppressive cells (MDSCs) has been considered a potential strategy in tumor therapy. However, a single drug targeting MDSCs remains a challenge in the clinic. An increasing number of studies have shown that combination agents targeting MDSCs and immunotherapy may provide exciting new insights and avenues to explore in tumor therapy. In our previous study, a novel cryo-thermal therapy was developed for metastatic tumors that systematically activate innate and adaptive immunity. Moreover, cryo-thermal therapy was shown to dramatically decrease the levels of MDSCs and induce their differentiation toward potent antigen-presenting cells. However, the therapeutic effects of cryo-thermal therapy on the 4T1 mouse breast cancer model were still not satisfactory because of the high level of MDSCs before and after treatment. Therefore, in this study, we combined cryo-thermal therapy with all-trans retinoid acid (ATRA), a small molecule drug that can induce the inflammatory differentiation of MDSCs. We found that combination therapy notably upregulated the long-term survival rate of mice. Mechanically, combination therapy promoted the phenotype and functional maturation of MDSCs, efficiently decreasing suppressive molecule expression and inhibiting glutamine and fatty acid metabolism. Moreover, MDSCs at an early stage after combination therapy significantly decreased the proportions of Th2 and Treg subsets, which eventually resulted in Th1-dominant CD4+ T-cell differentiation, as well as enhanced cytotoxicity of CD8+ T cells and natural killer cells at the late stage. This study suggests a potential therapeutic strategy for combination ATRA treatment targeting MDSCs with cryo-thermal therapy to overcome the resistance of MDSC-induced immunosuppression in the clinic. |
| first_indexed | 2024-04-13T14:36:03Z |
| format | Article |
| id | doaj.art-67692a9b28da4d61bf9e2b89016784a0 |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-04-13T14:36:03Z |
| publishDate | 2022-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-67692a9b28da4d61bf9e2b89016784a02022-12-22T02:43:02ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-11-011310.3389/fimmu.2022.10167761016776Combining all-trans retinoid acid treatment targeting myeloid-derived suppressive cells with cryo-thermal therapy enhances antitumor immunity in breast cancerYue LouPeng PengShicheng WangJunjun WangPeishan DuZelu ZhangJiamin ZhengPing LiuLisa X. XuTargeting myeloid-derived suppressive cells (MDSCs) has been considered a potential strategy in tumor therapy. However, a single drug targeting MDSCs remains a challenge in the clinic. An increasing number of studies have shown that combination agents targeting MDSCs and immunotherapy may provide exciting new insights and avenues to explore in tumor therapy. In our previous study, a novel cryo-thermal therapy was developed for metastatic tumors that systematically activate innate and adaptive immunity. Moreover, cryo-thermal therapy was shown to dramatically decrease the levels of MDSCs and induce their differentiation toward potent antigen-presenting cells. However, the therapeutic effects of cryo-thermal therapy on the 4T1 mouse breast cancer model were still not satisfactory because of the high level of MDSCs before and after treatment. Therefore, in this study, we combined cryo-thermal therapy with all-trans retinoid acid (ATRA), a small molecule drug that can induce the inflammatory differentiation of MDSCs. We found that combination therapy notably upregulated the long-term survival rate of mice. Mechanically, combination therapy promoted the phenotype and functional maturation of MDSCs, efficiently decreasing suppressive molecule expression and inhibiting glutamine and fatty acid metabolism. Moreover, MDSCs at an early stage after combination therapy significantly decreased the proportions of Th2 and Treg subsets, which eventually resulted in Th1-dominant CD4+ T-cell differentiation, as well as enhanced cytotoxicity of CD8+ T cells and natural killer cells at the late stage. This study suggests a potential therapeutic strategy for combination ATRA treatment targeting MDSCs with cryo-thermal therapy to overcome the resistance of MDSC-induced immunosuppression in the clinic.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1016776/fullcryo-thermal therapyall trans retinoid acidcombination therapymyeloid-derived suppressive cellsT cell immunity |
| spellingShingle | Yue Lou Peng Peng Shicheng Wang Junjun Wang Peishan Du Zelu Zhang Jiamin Zheng Ping Liu Lisa X. Xu Combining all-trans retinoid acid treatment targeting myeloid-derived suppressive cells with cryo-thermal therapy enhances antitumor immunity in breast cancer Frontiers in Immunology cryo-thermal therapy all trans retinoid acid combination therapy myeloid-derived suppressive cells T cell immunity |
| title | Combining all-trans retinoid acid treatment targeting myeloid-derived suppressive cells with cryo-thermal therapy enhances antitumor immunity in breast cancer |
| title_full | Combining all-trans retinoid acid treatment targeting myeloid-derived suppressive cells with cryo-thermal therapy enhances antitumor immunity in breast cancer |
| title_fullStr | Combining all-trans retinoid acid treatment targeting myeloid-derived suppressive cells with cryo-thermal therapy enhances antitumor immunity in breast cancer |
| title_full_unstemmed | Combining all-trans retinoid acid treatment targeting myeloid-derived suppressive cells with cryo-thermal therapy enhances antitumor immunity in breast cancer |
| title_short | Combining all-trans retinoid acid treatment targeting myeloid-derived suppressive cells with cryo-thermal therapy enhances antitumor immunity in breast cancer |
| title_sort | combining all trans retinoid acid treatment targeting myeloid derived suppressive cells with cryo thermal therapy enhances antitumor immunity in breast cancer |
| topic | cryo-thermal therapy all trans retinoid acid combination therapy myeloid-derived suppressive cells T cell immunity |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1016776/full |
| work_keys_str_mv | AT yuelou combiningalltransretinoidacidtreatmenttargetingmyeloidderivedsuppressivecellswithcryothermaltherapyenhancesantitumorimmunityinbreastcancer AT pengpeng combiningalltransretinoidacidtreatmenttargetingmyeloidderivedsuppressivecellswithcryothermaltherapyenhancesantitumorimmunityinbreastcancer AT shichengwang combiningalltransretinoidacidtreatmenttargetingmyeloidderivedsuppressivecellswithcryothermaltherapyenhancesantitumorimmunityinbreastcancer AT junjunwang combiningalltransretinoidacidtreatmenttargetingmyeloidderivedsuppressivecellswithcryothermaltherapyenhancesantitumorimmunityinbreastcancer AT peishandu combiningalltransretinoidacidtreatmenttargetingmyeloidderivedsuppressivecellswithcryothermaltherapyenhancesantitumorimmunityinbreastcancer AT zeluzhang combiningalltransretinoidacidtreatmenttargetingmyeloidderivedsuppressivecellswithcryothermaltherapyenhancesantitumorimmunityinbreastcancer AT jiaminzheng combiningalltransretinoidacidtreatmenttargetingmyeloidderivedsuppressivecellswithcryothermaltherapyenhancesantitumorimmunityinbreastcancer AT pingliu combiningalltransretinoidacidtreatmenttargetingmyeloidderivedsuppressivecellswithcryothermaltherapyenhancesantitumorimmunityinbreastcancer AT lisaxxu combiningalltransretinoidacidtreatmenttargetingmyeloidderivedsuppressivecellswithcryothermaltherapyenhancesantitumorimmunityinbreastcancer |